HealthDay on MSN
Calling low-risk prostate cancer something else might save more lives, researchers argue
Key Takeaways Renaming the lowest-grade prostate cancer to something other than cancer might save men’s livesThese GG1 cases ...
Morning Overview on MSN
Capivasertib won FDA approval for a hard-to-treat form of prostate cancer
Men diagnosed with metastatic prostate cancer that lacks the PTEN protein now have a targeted drug option for the first time.
Scientists are asking an unusual question: what if one type of prostate cancer should no longer be called cancer? A new ...
Our bodies are constantly deciding which cells should live and which should die through a process called apoptosis. This type ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results